SCHEMBL30366202

SCHEMBL30366202

CC(C)(C)OC(=O)N1CC[C@@H](c2ccc(Cl)cn2)[C@H](C(=O)O)C1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
USP2 O75604 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
USP30 Q70CQ3 2/20 0.44
STS P08842 1/20 0.43
PDE4B Q07343 1/20 0.42
LMNA P02545 2/20 0.42
GPR119 Q8TDV5 2/20 0.42
TP53 P04637 1/20 0.42
HPGDS O60760 1/20 0.41
NR3C1 P04150 1/20 0.41
TACR1 P25103 1/20 0.41
FAAH O00519 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30366230 1.00 MEN1 (0.46) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL23062504 0.92 MEN1 (0.46) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL30366151 0.88 MEN1 (0.45) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL30899631 0.88 MEN1 (0.45) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL30366333 0.84 PDE4B (0.43) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL30899632 0.84 PDE4B (0.43) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL529304 0.83 TACR1 (0.51) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL23982322 0.83 TACR1 (0.51) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL18741911 0.83 MEN1 (0.52) MEN1KMT2AUSP2HPGDNPSR1
SCHEMBL30294196 0.83 MEN1 (0.52) MEN1KMT2AUSP2HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405051-A1 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-07-31 EP disclosed
CN-118076604-A Pyrazolo [3,4-b ] pyridine compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2024-05-24 CN disclosed
WO-2023046806-A1 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-03-30 WO disclosed